Silo Pharma (SILO) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Silo Pharma Inc. announced its 2024 pipeline prioritization focusing on mental health, chronic pain, and neurology through a press release issued on February 1, 2024.
For further insights into SILO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.